Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC) - Wikidata - wikimedia - TriplyDB

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)

http://www.wikidata.org/entity/Q37163464

about

Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence Serous tubal intraepithelial carcinoma: an incidental finding at the time of prophylactic bilateral salpingo-oophorectomy.The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium.Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update.Low grade serious carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a "low-grade serous tubal intra-epithelial carcinoma" (STIC) on risk reducing surgery.Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.Opportunistic salpingectomy for ovarian cancer prevention Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.High-grade serous carcinoma of tubo-ovarian origin: recent developments.The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.Serous tubal intraepithelial carcinoma in a Japanese woman with a deleterious BRCA1 mutation.Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.Does one size fit all? The updated ovarian cancer staging: Still a work in progress.Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries.Who is at risk after risk reduction?Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum.

P2860

Q26747279-6F55386E-32C1-420B-9C0E-12D49F9988FE Q26748510-AF24EAF0-7417-419E-BC2B-0F159FF47680 Q26852127-35FB05E1-7728-4DC0-B17D-4DDC3D43CC36 Q30235845-0F1C0056-F2F0-4ADD-BCA8-27C560463152 Q30250107-DD07F1AF-FFB0-404C-A10F-3D2B69EF9EF6 Q30300317-D1E2FBB2-18E8-45A9-B1A8-678BFCA0D921 Q34498581-1CDF9928-57C6-4BDE-BDD8-779B6356B3F0 Q35155614-9918B6C8-A989-4D2D-A575-1367805F7AD9 Q35642063-43C0C04D-3119-456B-AB51-4494FAAE461C Q35749439-F223B3D4-5DCC-48BE-A9C1-930594643A37 Q36436803-9A26A5E0-321A-4E1A-88FF-58EAF4836844 Q36938143-26C67051-7859-4E8E-A986-43711A6D6EAF Q37598303-3E92DD26-5455-4FAD-BD3C-4E8BFCE82D38 Q38198705-905D14AF-5C53-494B-8D91-002D4280BB2D Q38687061-415E3803-2F08-4A80-B825-86CBE6E247EB Q38787667-B9AED11E-0969-4F24-95BD-9B5B765FFEA1 Q38912872-BBF0BC5C-945E-4636-9088-B47B5C8EE2AB Q38978839-34156D82-FD87-44F7-A0B4-BC0F8CB670EC Q39212515-6100080D-8C41-42E9-854C-6D524B3D009E Q39441988-192C06D5-E755-455F-9A76-D7A587D400A4 Q45015440-4D22507B-313C-44CE-BFB8-0A1C39B4FC77 Q47243819-DF28D527-8968-492B-BDAB-76B4447F1277 Q48283598-9C69EF02-E58F-47E0-B830-5CAC3BF54DD7 Q50964902-0F39B841-26B6-4C8F-9057-3F785E3C219F

P2860

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)

http://www.wikidata.org/entity/Q37163464

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)

@en

Clinical outcome of isolated serous tubal intraepithelial carcinomas

@nl

type

label

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)

@en

Clinical outcome of isolated serous tubal intraepithelial carcinomas

@nl

prefLabel

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)

@en

Clinical outcome of isolated serous tubal intraepithelial carcinomas

@nl

P1433

Q37163464-0EDED5DA-D9E4-4D83-AE20-BE304AF803CE

P1476

Q37163464-11929C14-2072-42DD-95C1-2820AB7D9C67

P2093

Q37163464-0A49E46F-D876-4885-A1E0-1F51C5CCF1D6

Q37163464-0C17F237-04B1-46CD-8C8F-67D41710AE12

Q37163464-17DECD07-D9D3-4385-A905-B7614489C504

Q37163464-1AB9F57E-9ED6-45A1-AC9A-12B88ECF50F2

Q37163464-4051F635-8356-4B01-BF45-5858782E8D79

Q37163464-565F137D-CCDF-41CA-98C8-B94D15E18540

Q37163464-7FA9CFE5-6716-4379-ACFD-A6C5C9586A05

Q37163464-82977D64-18F4-4B84-B506-FB6FC71D24F3

Q37163464-99A5318D-DB2B-4EAB-943E-E28048F68596

P2860

Q37163464-0E2865BB-2B54-4A71-B6C5-2DFAACE8337B

Q37163464-1B02B0DA-F830-481E-BCE5-686F3DFFD130

Q37163464-1B345031-CCBD-4455-B0F7-3D9F66D6CE6D

Q37163464-2B868341-D0B1-4317-B443-4BE5E144B17B

Q37163464-4105A43B-06B6-40D0-9698-4463033F1CD7

Q37163464-418BECBD-FB2D-44CC-A393-DF44FEE6C7BC

Q37163464-41D82C3C-F1B2-4180-86BF-4E0C9213BD02

Q37163464-6A94580E-691A-4EDA-B094-A5CA1E03BC66

Q37163464-782817D6-550A-406B-B4D2-F18D06CC2445

Q37163464-7999DD4F-98DC-4462-B76A-0C7523961C24

P304

Q37163464-D4DCE94C-CBF2-407D-ADDF-4933E1E020F6

P31

Q37163464-7510ED4F-2F8B-4D43-90C7-7856F8808C1D

P356

Q37163464-F2B3ECA0-6725-4F55-85A1-E22A82D3D5B5

P433

Q37163464-5435805A-6B9D-4329-9217-853B470565DC

P478

Q37163464-B5A31414-9F6E-45C2-8CBD-1F8A5C0090AB

P50

Q37163464-06CD4073-BA28-4F32-BBD3-5AE93131AC59

Q37163464-80BFE952-8DB5-4868-B6B4-85589604F9E6

Q37163464-87F7085A-2E91-40D6-AEEB-F373692F3E70

P577

Q37163464-EAC4C4E7-5E53-4C0A-91B3-44A2A74EA761

P698

Q37163464-9D167433-7749-4F17-8352-D0352ED69877

P932

Q37163464-D873785F-C4A1-4888-969E-0CDB2C626545

P356

IGC.0B013E3182A80AC8

P1433

International Journal of Gynecological Cancer

P1476

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)

@en

P2093

Carol L Brown

http://www.w3.org/2001/XMLSchema#string

Douglas A Levine

http://www.w3.org/2001/XMLSchema#string

Ebunoluwa Otegbeye

http://www.w3.org/2001/XMLSchema#string

Fanny Dao

http://www.w3.org/2001/XMLSchema#string

Ginger J Gardner

http://www.w3.org/2001/XMLSchema#string

Nadeem R Abu-Rustum

http://www.w3.org/2001/XMLSchema#string

Richard R Barakat

http://www.w3.org/2001/XMLSchema#string

Stephanie L Wethington

http://www.w3.org/2001/XMLSchema#string

Yukio Sonoda

http://www.w3.org/2001/XMLSchema#string

P2860

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.

Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers

Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.

Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.

P304

1603-1611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/IGC.0B013E3182A80AC8

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Robert A Soslow

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24172097

http://www.w3.org/2001/XMLSchema#string

P932

4979072

http://www.w3.org/2001/XMLSchema#string